Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial for preserving hair and reducing inflammation.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Targeting the AhR pathway may help treat alopecia areata.

Biopsy is crucial for diagnosing unusual hair loss causes like lymphoma.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Accurate diagnosis and treatment improved symptoms in a patient with alopecia linked to mycosis fungoides.

A new treatment plan helps manage folliculitis decalvans effectively.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Trichoscopy of the beard is useful for diagnosing frontal fibrosing alopecia in men.

The patient's hair loss is most likely due to diffuse alopecia areata.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

Follicular red dots can appear where alopecia areata and vitiligo overlap.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

A rare hair regrowth pattern can occur in some people with alopecia areata.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Botulinum toxin A may be an effective alternative treatment for the scalp disorder folliculitis decalvans.

Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.